找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Chemotherapy by Infusion; Jacob J. Lokich Book 1987 Precept Press, Inc. 1987 Staging.brain tumors.carcinoma.cell.classification.cli

[復(fù)制鏈接]
樓主: Boldfaced
31#
發(fā)表于 2025-3-27 00:42:02 | 只看該作者
32#
發(fā)表于 2025-3-27 04:12:57 | 只看該作者
Periwinkle Alkaloids I: Vinblastine and Vindesinehe mechanism of action of these drugs has been extensively reviewed elsewhere.. These drugs have a very high affinity for tubulin and inhibit its polymerization. This leads to mitotic arrest and subsequent cell death. The vinca alkaloids are most active against premitotic cells and thus are cell cycle phase-specific agents.
33#
發(fā)表于 2025-3-27 06:48:09 | 只看該作者
34#
發(fā)表于 2025-3-27 10:31:26 | 只看該作者
Bleomycinors, most notably testicular cancer, lymphomas, and squamous cell carcinoma of the head and neck. Its lack of myelotoxicity led to its early use in combination chemotherapy programs. The primary dose-limiting toxicity of bleomycin is pulmonary fibrosis.
35#
發(fā)表于 2025-3-27 17:07:44 | 只看該作者
36#
發(fā)表于 2025-3-27 19:50:40 | 只看該作者
37#
發(fā)表于 2025-3-27 22:17:46 | 只看該作者
38#
發(fā)表于 2025-3-28 04:07:57 | 只看該作者
39#
發(fā)表于 2025-3-28 09:55:57 | 只看該作者
rapy can no longer be viewed as simply a palliative contribution. Chemotherapy has assumed an important role as an adjuvant to other modalities, including both surgery and radiation therapy. For some tumors, the primary application of chemotherapy in a combined modality approach to curative therapy
40#
發(fā)表于 2025-3-28 10:31:12 | 只看該作者
Thomas L. Schwarz,Andrea J. Yools,. clinical use of the drug has been restricted to treatment of rapidly dividing tumors such as the leukemias. Recent interest has focused on ara-C as a potential differentiating agent when given in low doses over a prolonged infusion.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 08:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
枝江市| 桃江县| 临江市| 姚安县| 东莞市| 奉贤区| 土默特左旗| 富源县| 昌图县| 灵川县| 杭锦旗| 绥棱县| 泰顺县| 突泉县| 东源县| 安阳县| 揭东县| 永寿县| 盐边县| 乐陵市| 峡江县| 泰顺县| 晴隆县| 诸暨市| 武城县| 大足县| 天镇县| 鹤壁市| 海丰县| 遵义市| 安达市| 胶南市| 郑州市| 潢川县| 金塔县| 铁岭县| 屯留县| 高碑店市| 岳池县| 安西县| 阳新县|